JP2015131856A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015131856A5 JP2015131856A5 JP2015086575A JP2015086575A JP2015131856A5 JP 2015131856 A5 JP2015131856 A5 JP 2015131856A5 JP 2015086575 A JP2015086575 A JP 2015086575A JP 2015086575 A JP2015086575 A JP 2015086575A JP 2015131856 A5 JP2015131856 A5 JP 2015131856A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- compound
- cycloalkyl
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 51
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000000753 cycloalkyl group Chemical group 0.000 claims 13
- 150000001602 bicycloalkyls Chemical group 0.000 claims 6
- 125000004367 cycloalkylaryl group Chemical group 0.000 claims 6
- 230000004410 intraocular pressure Effects 0.000 claims 4
- 208000030533 eye disease Diseases 0.000 claims 3
- 208000010412 Glaucoma Diseases 0.000 claims 2
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24596009P | 2009-09-25 | 2009-09-25 | |
| US61/245,960 | 2009-09-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012531012A Division JP5893561B2 (ja) | 2009-09-25 | 2010-09-23 | 新規ｎｐｒ−ｂアゴニスト |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017101128A Division JP2017137362A (ja) | 2009-09-25 | 2017-05-22 | 新規ｎｐｒ−ｂアゴニスト |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015131856A JP2015131856A (ja) | 2015-07-23 |
| JP2015131856A5 true JP2015131856A5 (enExample) | 2016-05-12 |
| JP6211032B2 JP6211032B2 (ja) | 2017-10-11 |
Family
ID=43781057
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012531012A Expired - Fee Related JP5893561B2 (ja) | 2009-09-25 | 2010-09-23 | 新規ｎｐｒ−ｂアゴニスト |
| JP2015086575A Expired - Fee Related JP6211032B2 (ja) | 2009-09-25 | 2015-04-21 | 新規ｎｐｒ−ｂアゴニスト |
| JP2017101128A Withdrawn JP2017137362A (ja) | 2009-09-25 | 2017-05-22 | 新規ｎｐｒ−ｂアゴニスト |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012531012A Expired - Fee Related JP5893561B2 (ja) | 2009-09-25 | 2010-09-23 | 新規ｎｐｒ−ｂアゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017101128A Withdrawn JP2017137362A (ja) | 2009-09-25 | 2017-05-22 | 新規ｎｐｒ−ｂアゴニスト |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US8546523B2 (enExample) |
| EP (1) | EP2480247B1 (enExample) |
| JP (3) | JP5893561B2 (enExample) |
| KR (3) | KR20180049198A (enExample) |
| CN (2) | CN102548574B (enExample) |
| AR (1) | AR078445A1 (enExample) |
| AU (1) | AU2010298256B2 (enExample) |
| BR (1) | BR112012006579A2 (enExample) |
| CA (1) | CA2773949C (enExample) |
| CL (2) | CL2012000715A1 (enExample) |
| MX (3) | MX2012003398A (enExample) |
| PH (1) | PH12012500562A1 (enExample) |
| RU (3) | RU2636738C2 (enExample) |
| TW (2) | TWI577384B (enExample) |
| UY (1) | UY32902A (enExample) |
| WO (1) | WO2011038061A2 (enExample) |
| ZA (3) | ZA201201630B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7732406B2 (en) | 2005-04-07 | 2010-06-08 | Cardiopep Pharma Gmbh | Use of natriuretic peptide for treating heart failure |
| JP5345532B2 (ja) * | 2006-08-02 | 2013-11-20 | ヨハネス・グーテンベルク−ウニヴェルジテート・マインツ | Ｌｃｔ中毒に対する医薬品 |
| PH12012500562A1 (en) | 2009-09-25 | 2012-10-22 | Takeda Pharmaceuticals Co | Novel npr-b antagonists |
| TW201121995A (en) | 2009-12-18 | 2011-07-01 | Alcon Res Ltd | Novel NPR-B agonists |
| CA2853204A1 (en) * | 2011-12-16 | 2013-06-20 | Kalos Therapeutics, Inc. | Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases |
| NZ710246A (en) * | 2013-01-25 | 2016-11-25 | Cardiorentis Ltd | Methods of treating cardiovasular indications |
| SI3464336T1 (sl) | 2016-06-01 | 2022-06-30 | Athira Pharma, Inc. | Spojine |
| EP3576770A1 (en) * | 2017-02-01 | 2019-12-11 | Shire Human Genetic Therapies, Inc. | Compounds and compositions for the treatment of ophthalmic disorders |
| CA3056433A1 (en) | 2017-03-22 | 2018-09-27 | Pharmain Corporation | Npra agonists, compositions, and uses thereof |
| US20210121534A1 (en) * | 2018-06-19 | 2021-04-29 | Cella Therapeutics, Llc | Sustained-release drug delivery systems comprising an intraocular pressure lowering agent, a cnp compound, an npr-b compound, a tie-2 agonist, or neurotrophic agent for use for treating glaucoma or ocular hypertension |
| EP3880685B1 (en) * | 2018-11-16 | 2025-06-18 | Arcus Biosciences, Inc. | Inhibitors of arg1 and/or arg2 |
| US20230416328A1 (en) * | 2020-06-12 | 2023-12-28 | Hirofumi Tachibana | C-Type Natriuretic Peptides and Methods Thereof in Treating Acute Lung Injury |
| KR102677730B1 (ko) * | 2023-03-27 | 2024-06-27 | 나인바이오팜 주식회사 | 지방 분해 효능을 갖는 펩타이드 및 이의 용도 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757048A (en) | 1985-11-05 | 1988-07-12 | Biotechnology Research Associates J.V. | Synthetic analogs of atrial natriuretic peptides |
| EP0323740A3 (en) * | 1987-12-24 | 1990-12-12 | California Biotechnology, Inc. | Linear analogs of atrial natriuretic peptides |
| JP2848411B2 (ja) * | 1988-08-18 | 1999-01-20 | サイオス インコーポレイテッド | 心房性ナトリウム利尿ペプチドクリアランス阻害剤 |
| EP1118329A4 (en) | 1998-09-28 | 2004-12-15 | Santen Pharmaceutical Co Ltd | LACRYMAL SECRETION PROMOTERS OR OPHTHALMOLOGICAL DROPS CONTAINING NATRIURETIC PEPTIDES AS ACTIVE INGREDIENTS FOR TREATING KERATOCONJUNCTIVITY |
| US20040266673A1 (en) * | 2002-07-31 | 2004-12-30 | Peter Bakis | Long lasting natriuretic peptide derivatives |
| US6025198A (en) | 1999-06-25 | 2000-02-15 | Isis Pharmaceuticals Inc. | Antisense modulation of Ship-2 expression |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| IL142118A0 (en) * | 2001-03-20 | 2002-03-10 | Prochon Biotech Ltd | Method and composition for treatment of skeletal dysplasias |
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| US7648962B2 (en) * | 2002-11-26 | 2010-01-19 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
| US7297709B2 (en) * | 2003-05-22 | 2007-11-20 | Abbott Laboratories | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| WO2006005140A2 (en) * | 2004-07-15 | 2006-01-19 | The University Of Queensland | Proteinaceous compounds and uses therefor |
| TW200640443A (en) * | 2005-02-23 | 2006-12-01 | Alcon Inc | Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors |
| WO2007034498A1 (en) * | 2005-09-26 | 2007-03-29 | Compugen Ltd. | Atrial natriuretic peptide (anp) splice variants and methods of using same |
| CA2625600A1 (en) * | 2005-10-14 | 2007-04-26 | Biorexis Pharmaceutical Corporation | Natriuretic peptide modified transferrin fusion proteins |
| AU2007233116B2 (en) * | 2006-03-30 | 2013-05-09 | Palatin Technologies, Inc. | Cyclic natriuretic peptide constructs |
| AU2007233123A1 (en) * | 2006-03-30 | 2007-10-11 | Palatin Technologies, Inc. | Linear natriuretic peptide constructs |
| AR069409A1 (es) * | 2007-11-21 | 2010-01-20 | Biomarin Pharm Inc | Variantes de peptidos natriureticos de tipo c |
| PH12012500562A1 (en) | 2009-09-25 | 2012-10-22 | Takeda Pharmaceuticals Co | Novel npr-b antagonists |
| US8551938B2 (en) | 2009-09-25 | 2013-10-08 | Alcon Research, Ltd. | NPR-B agonists |
| TW201121995A (en) | 2009-12-18 | 2011-07-01 | Alcon Res Ltd | Novel NPR-B agonists |
-
2010
- 2010-09-23 PH PH1/2012/500562A patent/PH12012500562A1/en unknown
- 2010-09-23 MX MX2012003398A patent/MX2012003398A/es active IP Right Grant
- 2010-09-23 CN CN201080042799.0A patent/CN102548574B/zh not_active Expired - Fee Related
- 2010-09-23 KR KR1020187012130A patent/KR20180049198A/ko not_active Ceased
- 2010-09-23 WO PCT/US2010/049912 patent/WO2011038061A2/en not_active Ceased
- 2010-09-23 US US12/888,556 patent/US8546523B2/en not_active Expired - Fee Related
- 2010-09-23 KR KR1020127010423A patent/KR101768661B1/ko not_active Expired - Fee Related
- 2010-09-23 RU RU2015124607A patent/RU2636738C2/ru active
- 2010-09-23 AU AU2010298256A patent/AU2010298256B2/en not_active Ceased
- 2010-09-23 JP JP2012531012A patent/JP5893561B2/ja not_active Expired - Fee Related
- 2010-09-23 RU RU2012116531/04A patent/RU2557290C2/ru active
- 2010-09-23 MX MX2014001528A patent/MX354005B/es unknown
- 2010-09-23 MX MX2017012681A patent/MX370645B/es unknown
- 2010-09-23 KR KR1020177022310A patent/KR101854820B1/ko not_active Expired - Fee Related
- 2010-09-23 EP EP10819424.2A patent/EP2480247B1/en active Active
- 2010-09-23 BR BR112012006579A patent/BR112012006579A2/pt not_active Application Discontinuation
- 2010-09-23 CA CA2773949A patent/CA2773949C/en not_active Expired - Fee Related
- 2010-09-23 CN CN201610116122.6A patent/CN105732767A/zh active Pending
- 2010-09-23 UY UY0001032902A patent/UY32902A/es not_active Application Discontinuation
- 2010-09-24 TW TW099132370A patent/TWI577384B/zh not_active IP Right Cessation
- 2010-09-24 TW TW104137551A patent/TWI625126B/zh not_active IP Right Cessation
- 2010-09-24 AR ARP100103479A patent/AR078445A1/es active IP Right Grant
-
2012
- 2012-03-05 ZA ZA2012/01630A patent/ZA201201630B/en unknown
- 2012-03-22 CL CL2012000715A patent/CL2012000715A1/es unknown
-
2013
- 2013-08-28 US US14/011,855 patent/US9169293B2/en not_active Expired - Fee Related
-
2014
- 2014-03-04 ZA ZA2014/01625A patent/ZA201401625B/en unknown
-
2015
- 2015-04-21 JP JP2015086575A patent/JP6211032B2/ja not_active Expired - Fee Related
- 2015-08-12 US US14/824,353 patent/US9745344B2/en not_active Expired - Fee Related
-
2017
- 2017-04-26 ZA ZA2017/02958A patent/ZA201702958B/en unknown
- 2017-05-11 CL CL2017001190A patent/CL2017001190A1/es unknown
- 2017-05-22 JP JP2017101128A patent/JP2017137362A/ja not_active Withdrawn
- 2017-07-10 US US15/645,680 patent/US9982016B2/en not_active Expired - Fee Related
- 2017-11-16 RU RU2017139870A patent/RU2017139870A/ru unknown
-
2018
- 2018-05-09 US US15/975,172 patent/US10196423B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017515901A5 (enExample) | ||
| CN107995862B8 (zh) | 包含sglt-2抑制剂之液态药物组合物 | |
| MX376106B (es) | Nuevas piridazonas y triazinonas para el tratamiento y la profilaxis de infección por virus de hepatitis b. | |
| MX382837B (es) | Composición y método para el crecimiento del pelo. | |
| MX421406B (es) | Composiciones de acido ribonucleico de interferencia (arni) contra el virus de la hepatitis b (hbv) y metodos de uso de estas | |
| EA201790630A1 (ru) | Способы получения рибозидов | |
| JP2015504081A5 (enExample) | ||
| MX384315B (es) | Agente para el tratamiento y/o prevención de enfermedades asociadas con anormalidades inmunes. | |
| SA519401435B1 (ar) | مركبات حلقية ثنائية النيوكليوتيد | |
| MX390302B (es) | Oxiesteroles y metodos de uso de los mismos | |
| WO2015106128A3 (en) | Rnai agents modified at the 4'-c-position | |
| UY36465A (es) | Compuestos policíclicos de carbamoilpiridona y su uso farmacéutico | |
| JP2016518437A5 (enExample) | ||
| JP2015504909A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| EA201592146A1 (ru) | Гетероароматические соединения и их применение в качестве лигандов к дофаминовым d1-рецепторам | |
| MX2020010690A (es) | Oxiesteroles y metodos de uso de los mismos. | |
| JP2018501215A5 (enExample) | ||
| JP2011137045A5 (enExample) | ||
| HK1255500A1 (zh) | 氧固醇及其使用方法 | |
| JP2016505637A5 (enExample) | ||
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| JP2017518982A5 (enExample) | ||
| MX2023002994A (es) | Formas de dosificacion oral y de liberacion controlada gastrorresistentes. | |
| CN111526878A (zh) | 含三萜类化合物的药物组合物及其用途 |